Move is Part of Growing Sales, Marketing and Strategic Partnership Activities in the United States
Toronto, Ontario--(Newsfile Corp. - February 21, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or
the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and
management software solutions, confirms it has retained Whiteford, Taylor & Preston L.L.P. to assist in software licensing and
intellectual property business matters on a go forward basis.
Whiteford, Taylor & Preston includes over 170 attorneys in sixteen offices located in Delaware, the District of Columbia,
Kentucky, Maryland, Michigan, New York, Pennsylvania and Virginia, and is one of the mid-Atlantic's leading law firms.
As new opportunities develop in the US, the Company will be well served with representation from a firm located in the United
States with experience in identifying, protecting, expanding and leveraging the Company's technologies and IP assets. Further,
Whiteford, Taylor & Preston meets the Company's need for guidance from a firm with expertise in working with a medical software
company that does business in both hospital and large institutional environments, as well as the consumer health and wellness
sectors.
To learn more about CardioComm's products and for further updates regarding software releases and new device integrations,
please visit the Company's websites at www.cardiocommsolutions.com and
www.theheartcheck.com.
About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing
electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an
external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485:2016
certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health
Canada).
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
egrima@cardiocommsolutions.com
investor.relations@cardiocommsolutions.com
Forward-looking statements
This release may contain certain forward-looking statements and forward-looking information with respect to the financial
condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm
Solutions with respect to these items. Such statements and information reflect management's current beliefs and are based on
information currently available to management. By their nature, forward-looking statements and forward-looking information involve
risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many
factors that could cause actual results and developments to differ materially from those expressed or implied by these
forward-looking statements and forward-looking information.
In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking
information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information
contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National
Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this release.
![Corporate Logo](https://orders.newsfilecorp.com/files/1775/42973_3693524744cd7863_logo.jpg)
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/42973